Vanderbilt-Ingram Cancer Center: all 223 studies

Page 1 of 3. Open to participants first (33), then studies with results posted, then the rest; newest registration first within each.

• Cemiplimab and Quad Shot Radiation for Cutaneous Squamous Cell Carcinoma in the Head and NeckRecruitingNCT07869823Early Phase 1
• PhII Study of Toripalimab Followed by Definitive CRT & Adjuvant Toripalimab in Locally Advanced ESCCNot yet recruitingNCT07836049Phase 2
• Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin LymphomaRecruitingNCT07763210Phase 2
• Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell CarcinomaRecruitingNCT07748988Phase 1
• Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell CarcinomaRecruitingNCT07741643Phase 1
• Window Trial of Intratumoral (IT) Neoadjuvant Fluorescently Labelled Nivolumab (nivo800) in Head and Neck Squamous Cell Carcinoma (HNSCC)RecruitingNCT07741565Early Phase 1
• Nemtabrutinib With CAR T Therapy in Relapsed/Refractory Mantle Cell LymphomaRecruitingNCT07673367Phase 2
• Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)RecruitingNCT07460765Phase 1
• Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell CarcinomaRecruitingNCT07217028Phase 1
• High-Resolution PET-CT Imaging for Surgical Margin VisualizationRecruitingNCT06915454Not applicable
• Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted TherapyRecruitingNCT06828588Early Phase 1
• Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck CancerRecruitingNCT06819228Phase 1
• The Clonal Hematopoiesis & Inflammation in Vasculature Registry and BiorepositoryRecruitingNCT06701214
• Cohort to Augment the Understanding of Sarcoma Survivorship Across the LifespanRecruitingNCT06482957
• Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid LeukemiaRecruitingNCT06399640Phase 1
• Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body IrradiationRecruitingNCT06110572Phase 1/2
• EBUS-TBNA vs Transbronchial Mediastinal Cryobiopsy for Adequacy of Next Generation SequencingRecruitingNCT06105801Phase 4
• Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine TumorsRecruitingNCT06016855Phase 4
• Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation TherapyRecruitingNCT05996432Early Phase 1
• Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck CancerRecruitingNCT05945875Phase 1
• Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast CancersRecruitingNCT05919108Phase 2
• Evaluating 111In Panitumumab for Nodal Staging in Head and Neck CancerRecruitingNCT05901545Phase 1
• Circulating Tumor DNA to Guide Changes in Standard of Care ChemotherapyRecruitingNCT05770531Phase 2
• Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung CancerRecruitingNCT05501665Phase 1/2
• Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC StudyRecruitingNCT05361720Phase 2
• Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue SarcomasRecruitingNCT04506008Phase 2
• Studying Health Outcomes After Treatment in Patients With RetinoblastomaRecruitingNCT03932786
• Finding the Cause for Post-Transplant Diabetes Mellitus After Allogeneic Hematopoietic Cell TransplantRecruitingNCT03415139
• Inherited CAncer REgistryRecruitingNCT03231891
• Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of TreatmentRecruitingNCT01205815
• Collecting and Storing Tissue Samples From Women With or Without Breast CancerRecruitingNCT00899301
• Molecular Predictors of Cancer in Patients at High Risk of Lung CancerRecruitingNCT00898313
• Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung CancerRecruitingNCT00897117
• Rigosertib Plus Pembrolizumab in Treating Patients With Unresectable/Metastatic Melanoma Refractory to PD-1 InhibitorsTerminatedNCT05764395Phase 2Results posted
• Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient SettingCompletedNCT05108805Phase 4Results posted
• Metabolism Informed Smoking Treatment: The MIST RCTCompletedNCT04590404Phase 3Results posted
• Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct SystemTerminatedNCT04327999Phase 2Results posted
• Impact of Human-Animal Interactions on Children With Life-Threatening Conditions and Their ParentsCompletedNCT04310345Not applicableResults posted
• Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During ParathyroidectomyCompletedNCT04299425Not applicableResults posted
• Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy.CompletedNCT04281875Not applicableResults posted
• Navigation Endoscopy to Reach Indeterminate Lung Nodules Versus Trans-Thoracic Needle AspirationCompletedNCT04250194Not applicableResults posted
• Central Pain Syndrome in Survivors of Head and Neck CancerTerminatedNCT04128267Not applicableResults posted
• Tumor-Treating Fields Therapy in Preventing Brain Tumors in Participants With Extensive-Stage Small Cell Lung CancerTerminatedNCT03607682Not applicableResults posted
• Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic TumorsCompletedNCT03583086Phase 1/2Results posted
• Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast CancerTerminatedNCT03566485Phase 1/2Results posted
• Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal CancerCompletedNCT03263429Phase 1/2Results posted
• Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase InhibitorsCompletedNCT03238248Phase 2Results posted
• Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast CancerCompletedNCT03238196Phase 1Results posted
• Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast CancerCompletedNCT03206203Phase 2Results posted
• High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant RecipientsCompletedNCT03179761Phase 2Results posted
• Safety and Efficacy of Avelumab in Small Intestinal AdenocarcinomaTerminatedNCT03000179Phase 2Results posted
• Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell TransplantCompletedNCT02869633Phase 2Results posted
• High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell TransplantCompletedNCT02860039Phase 2Results posted
• Chemoprevention of Gastric CarcinogenesisCompletedNCT02794428Phase 2Results posted
• Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid LeukemiaCompletedNCT02658487Phase 2Results posted
• Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation TherapyCompletedNCT02480114Phase 3Results posted
• Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast CancerTerminatedNCT02457910Phase 1/2Results posted
• 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary NodulesCompletedNCT02448225Phase 2Results posted
• Pembrolizumab in Treating Patients With Advanced Uveal MelanomaTerminatedNCT02359851Phase 2Results posted
• Trametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 MutationsCompletedNCT02296112Phase 2Results posted
• FDG-PET in Advanced MelanomaTerminatedNCT02236546Not applicableResults posted
• 3-Tesla MRI Response to TACE in HCC (Liver Cancer)TerminatedNCT02057874Not applicableResults posted
• GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast CancerTerminatedNCT01918306Phase 1/2Results posted
• Non-Myeloablative Conditioning and Bone Marrow TransplantationActive, not recruitingNCT01850108Not applicableResults posted
• Dabrafenib Alone and in Combination With Trametinib Before Surgery in Treating Patients With Locally or Regionally Advanced Melanoma That Can Be Removed By SurgeryTerminatedNCT01701037Phase 2Results posted
• 68Ga-DOTATATE PET Scan in Neuroendocrine CancerCompletedNCT01396382Phase 2Results posted
• Linifanib in Treating Patients With Advanced, Refractory Colorectal CancerTerminatedNCT01365910Phase 2Results posted
• Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV MelanomaTerminatedNCT01316692Phase 2Results posted
• PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas CancerTerminatedNCT01227018Phase 2Results posted
• PET/CT Evaluation of Treatment Response in Breast CancerTerminatedNCT01222416Not applicableResults posted
• Standard vs High-Dose Trivalent Inactivated Flu Vaccine in Adult Hematopoetic Stem Cell Transplant (HSCT) RecipientsCompletedNCT01215734Phase 1Results posted
• First Autologous Transplant on Minimal Residual Disease Markers in Previously Untreated Myeloma Undergoing Initial Treatment With VelcadeCompletedNCT01215344Phase 2Results posted
• Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast CancerTerminatedNCT01205685Phase 2Results posted
• Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast CancerCompletedNCT01031446Phase 1/2Results posted
• Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung CancerCompletedNCT00984542Phase 2Results posted
• Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By SurgeryTerminatedNCT00984490Not applicableResults posted
• Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast CancerCompletedNCT00930930Phase 2Results posted
• Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT00837876Phase 2Results posted
• Lenalidomide With or Without Rituximab After Standard Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin LymphomaCompletedNCT00765245Phase 2Results posted
• Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure DisorderCompletedNCT00755040Phase 3Results posted
• Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer PainCompletedNCT00666211Phase 3Results posted
• Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00664105Phase 2Results posted
• Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary AdenocarcinomaTerminatedNCT00653328Phase 2Results posted
• Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00639769Phase 2Results posted
• Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by SurgeryCompletedNCT00633750Phase 2Results posted
• Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer.TerminatedNCT00611715Phase 2Results posted
• Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate MofetilTerminatedNCT00608517Not applicableResults posted
• Healing Touch in Treating Fatigue in Women Undergoing Radiation Therapy for Breast CancerCompletedNCT00574145Not applicableResults posted
• Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00550537Phase 2Results posted
• Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLCTerminatedNCT00544648Phase 1/2Results posted
• Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung CancerTerminatedNCT00520845Phase 2Results posted
• Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction CancerCompletedNCT00514020Phase 2Results posted
• Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or MelanomaTerminatedNCT00512798Phase 1/2Results posted
• Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck CancerCompletedNCT00503997Phase 2Results posted
• Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & DysphagiaTerminatedNCT00503776Phase 2Results posted
• PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORETerminatedNCT00499681Phase 2Results posted
• ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyTerminatedNCT00471718Phase 1/2Results posted
• Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00469898Phase 2Results posted
• Erlotinib and Bevacizumab in Treating Patients With Stage IV MelanomaCompletedNCT00466687Phase 2Results posted
• Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by SurgeryCompletedNCT00466505Phase 2Results posted

← Vanderbilt-Ingram Cancer Center overview and focus areas